Send to

Choose Destination
See comment in PubMed Commons below
Cancer Res. 2001 Jun 1;61(11):4311-4.

Molecular identification of latent precancers in histologically normal endometrium.

Author information

  • 1Department of Pathology, Brigham and Women's Hospital, 75Francis Street, Boston, MA 02115, USA.


Discovery of somatically mutated cells in human tissues has been less frequent than would be predicted by in vitro mutational rates. We analyzed the PTEN tumor suppressor gene as an early marker for endometrial carcinogenesis, and we show that 43% of histologically normal premenopausal endometria contain rare glands that fail to express PTEN protein because of mutation and/or deletion. These persist between menstrual cycles. Histopathology of PTEN-null glands is initially unremarkable, but with progression, they form distinctive high-density clusters. These data are consistent with a progression model in which initial mutation is not rate limiting.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center